Correlation between BM mast cell infiltration and serum tryptase levels in patients with or without additional molecular aberrations
| . | Additional mutation(s) (n = 27) . | No additional mutation(s) (n = 12) . | All (n = 39) . |
|---|---|---|---|
| BM infiltration (%) (Median, range) | 30 (10-70) | 25 (10-60) | 30 (10-80) |
| P = .50 | |||
| Tryptase (μg/L) (Median, range) | 174 (30-999) | 101 (8-999) | 154 (8-999) |
| P = .34 |
| . | Additional mutation(s) (n = 27) . | No additional mutation(s) (n = 12) . | All (n = 39) . |
|---|---|---|---|
| BM infiltration (%) (Median, range) | 30 (10-70) | 25 (10-60) | 30 (10-80) |
| P = .50 | |||
| Tryptase (μg/L) (Median, range) | 174 (30-999) | 101 (8-999) | 154 (8-999) |
| P = .34 |
BM, bone marrow.